SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Offer Update

10 Dec 2007 07:01

OAO Severstal10 December 2007 10 December 2007 RECOMMENDED REVISED CASH OFFER BY CENTROFERVE LIMITED A WHOLLY OWNED SUBSIDIARY OF SEVERSTAL FOR CELTIC RESOURCES HOLDINGS PLC OFFER UNCONDITIONAL AS TO ACCEPTANCES Centroferve, a wholly owned subsidiary of Severstal, announces that, as at 3.00p.m. on Friday 7 December 2007, acceptances of the Offer had been received inrespect of 45,294,217 Celtic Shares (representing approximately 81.1% of theCeltic Shares to which the Offer relates) and that, accordingly, the Offer isunconditional as to acceptances. If the Offer is declared unconditional in all respects, Celtic Shareholders whohave accepted or accept the Offer while it remains open for acceptance willreceive aggregate cash consideration of £2.90 per Celtic Share becauseCentroferve has received acceptances of the Offer in respect of 80% in value ofthe Celtic Shares for which the Offer was made, and the contingent cashconsideration described in the Revised Offer Document has therefore becomepayable. Having received acceptances of the Offer in respect of 80% of the Celtic Sharesto which the Offer relates, if the Offer is declared unconditional in allrespects Centroferve intends to exercise its right pursuant to the provisions ofSection 204 of the Companies Act 1963 to acquire the remaining Celtic Shares towhich the Offer relates on the same terms as the Offer. Centroferve did not hold any Celtic Shares before the commencement of the OfferPeriod and has not acquired or agreed to acquire any Celtic Shares during theOffer Period. Prior to the Offer Period, Bluecone, a company owned by Severstal, acquired12,281,946 Celtic Shares, and during the Offer Period (but before the OriginalOffer was made) Bluecone acquired a further 4,301,056 Celtic Shares. As aresult, Bluecone owns 16,583,002 Celtic Shares representing approximately 29.7%of the issued share capital of Celtic, and the acceptances referred to aboveinclude an acceptance of the Offer by Bluecone in respect of all of the CelticShares held by Bluecone. Other than the Celtic Shares held or acquired by Bluecone, no party acting inconcert with Centroferve held before the commencement of the Offer Period, oracquired or agreed to acquire during the Offer Period, any Celtic Shares. Terms defined in the Revised Offer Document dated 20 November 2007 have the samemeaning in this announcement unless otherwise stated. The Offer remains open for acceptance until 3.00pm (Dublin time) on 28 December2007. Enquiries: Centroferve Tel: +7 495 9810 910 ext.6633 Roman Deniskin Nikolai Zelenski Morgan Stanley & Co. Limited Tel: +44 20 7425 8000 Peter Bacchus Arash Mahdaviani FD London Tel: +44 207 831 3113 Jon Simmons Ben Brewerton The directors of Centroferve and the directors of Severstal acceptresponsibility for the information contained in this announcement. To the bestof the knowledge and belief of the directors of Centroferve and the directors ofSeverstal (who have taken all reasonable care to ensure that such is the case),the information contained in this announcement for which they acceptresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. Morgan Stanley & Co. Limited ("Morgan Stanley") is acting exclusively forCentroferve and Severstal Resurs and no one else in connection with the Offerand Morgan Stanley will not regard any other person as a client in relation tothe Offer and will not be responsible to anyone other than Centroferve andSeverstal Resurs for providing the protections afforded exclusively to itsclients or for providing advice in relation to the Offer, the contents of thisannouncement or any transaction or arrangement referred to herein. The Offer will not be made, directly or indirectly, in or into any jurisdictionwhere it would be unlawful to do so, or by use of the mails, or by any means orinstrumentality (including, without limitation, telephonically orelectronically) of interstate or foreign commerce, or by any facility of anational securities exchange of any jurisdiction where it would be unlawful todo so, and the Offer will not be capable of acceptance by any such means,instrumentality or facility from or within any jurisdiction where it would beunlawful to do so. Accordingly, copies of this announcement and all otherdocuments relating to the Offer are not being, and must not be, mailed orotherwise forwarded, distributed or sent in, into or from any jurisdiction whereit would be unlawful to do so. Persons receiving such documents (including,without limitation, nominees, trustees and custodians) should observe theserestrictions. Failure to do so may invalidate any related purported acceptanceof the Offer. Notwithstanding the foregoing restrictions, Centroferve reservesthe right to permit the Offer to be accepted if, in its sole discretion, it issatisfied that the transaction in question is exempt from or not subject to thelegislation or regulation giving rise to the restrictions in question. This announcement does not constitute an offer to sell or an invitation topurchase or the solicitation of an offer to purchase or subscribe for anysecurities. Any response in relation to the Offer should be made only on thebasis of the information contained in the Revised Offer Document or any documentby which the Offer is made. Any person who is a holder of 1% or more of the Celtic Shares may havedisclosure obligations under Rule 8.3 of the Takeover Rules, effective from thedate of the commencement of the Offer Period. The Offer will be made in the United States pursuant to an exemption from the UStender offer rules provided by Rule 14d-1(c) under the US Exchange Act. Notice to US holders of Celtic Shares: The Offer will be made for the securities of an Irish public limited companywhose shares are listed on the AIM market in the UK and is subject to Irish andUK disclosure requirements, which are different from those of the United States.The Offer will be made in the United States pursuant to applicable US tenderoffer rules and otherwise in accordance with the requirements of the IrishTakeover Rules. Accordingly, the Offer will be subject to disclosure and otherprocedural requirements, including with respect to withdrawal rights, offertimetable, settlement procedures and timing of payments that are different fromthose applicable under US domestic tender offer procedures and law. The receipt of cash pursuant to the Offer by a US holder of Celtic Shares may bea taxable transaction for US federal income tax purposes and under applicable USstate and local, as well as foreign and other tax laws. Each holder of CelticShares is urged to consult his independent professional adviser immediatelyregarding the tax consequences of acceptance of the Offer. It may be difficult for US holders of Celtic Shares to enforce their rights andany claim arising out of the US federal securities laws, since Centroferve andCeltic are located in non-US jurisdictions, and some or all of their officersand directors may be residents of non-US jurisdictions. US holders of CelticShares may not be able to sue a non-US company or its officers or directors in anon-US court for violations of the US securities laws. Further, it may bedifficult to compel a non-US company and its affiliates to subject themselves toa US court's judgement. In accordance with normal Irish and UK practice and pursuant to Rule 14e-5(b) ofthe US Exchange Act, Centroferve or its nominees, or its brokers (acting asagents), may from time to time make certain purchases of, or arrangements topurchase, Celtic Shares outside the United States, other than pursuant to theOffer, before or during the period in which the Offer remains open foracceptance. These purchases may occur either in the open market at prevailingprices or in private transactions at negotiated prices. Any information aboutsuch purchases will be disclosed as required in Ireland and the UK, will bereported to a Regulatory Information Service of the UK Listing Authority andwill be available on the London Stock Exchange website, www.londonstockexchange.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jun 20265:50 pmRNSPDMR Dealing
1st Jun 20267:00 amRNSInterim Results
19th May 20267:00 amRNSInterim Results Investor Presentation
24th Apr 20262:46 pmRNSTR-1 Notification
22nd Apr 20267:00 amRNSH1 Trading Update
17th Apr 20268:00 amRNSExcercise of Options, Total Voting Rights
14th Apr 20267:00 amRNSCFO Joining Date and Date of Trading Update
9th Apr 202611:43 amRNSTR-1 Notification
27th Mar 20267:00 amRNSTR-1 Notification
26th Mar 20267:00 amRNS-RAchieves "Diamond-level" Open API Certification
5th Mar 202611:44 amRNSGrant of Options
19th Feb 20263:38 pmRNSResult of AGM
18th Feb 20267:00 amRNSNotification of Major Interest in Cerillion
13th Feb 202610:24 amRNSExercise of Options, Total Voting Rights
6th Feb 202610:37 amRNSExercise of Options, TVR, Block Admission Return
2nd Feb 202612:45 pmRNSExercise of Options and Total Voting Rights
28th Jan 20267:00 amRNSBoard Change - CFO Transition
14th Jan 20266:15 pmRNSExcercise of Options and Share Purchase
12th Jan 20269:15 amRNSPosting of Report and Accounts & Notice of AGM
8th Jan 20267:00 amRNSMajor Contract Win
2nd Dec 20255:19 pmRNSTR-1 Notification
24th Nov 20255:56 pmRNSExcercise of Options, PDMR Dealing
24th Nov 20257:00 amRNSFinal Results
3rd Nov 20257:00 amRNSNotice of Final Results
29th Oct 20257:00 amRNS-RLaunch of Cerillion 25.2
23rd Oct 20258:01 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFull Year Trading Update
25th Sep 20257:00 amRNS-RNamed in IDC MarketScape 2025 Assessment
8th Sep 20257:00 amRNSMajor follow-on contracts worth £17.3m
2nd Sep 20257:00 amRNS-RCerillion Recognised in two Gartner Reports
30th Jul 20257:00 amRNSExercise of Options, PDMR dealing and TVR
2nd Jul 20251:14 pmRNSEmployee Share Option Scheme and PDMR dealing
16th Jun 20257:00 amRNSTR-1 Notification
13th Jun 20257:47 amRNSPDMR shareholding - replacement
12th Jun 20251:50 pmRNSResult of Secondary Share Sale
11th Jun 20254:54 pmRNSProposed Secondary Placing
10th Jun 20256:30 pmRNSPDMR Shareholding
5th Jun 20257:37 amRNSDirector/PDMR Shareholding
19th May 20257:00 amRNSInterim Results
16th May 20251:29 pmRNSResult of General Meeting
12th May 20257:00 amRNSNotice of Results and Investor Presentation
30th Apr 20259:06 amRNSNotice of General Meeting
29th Apr 20253:51 pmRNSTR-1 Notification
14th Apr 20257:00 amRNSHalf-year Trading Update
17th Mar 20257:00 amRNSShare Purchase
13th Feb 20254:25 pmRNSResult of AGM
24th Jan 20259:51 amRNSPDMR Shareholding
22nd Jan 20259:35 amRNSPDMR Shareholding
20th Jan 20257:00 amRNSMajor New Contract
15th Jan 20257:00 amRNSShare purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.